seed
Stage
1
Investors
About
Synlogic engineers synthetic probiotic bacteria to develop living therapeutics aimed at treating rare metabolic and serious diseases.
Explore Synlogic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.